QA: Biomarin Pharmaceutical INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001048477_2013_Biomarin_Pharmaceutical_INC.pdf

Logs

Graph

Absolute values for 0001048477, Biomarin Pharmaceutical INC

  xvar xval
0 AssetsCurrent 743,462,000
1 IntangibleAssetsNetIncludingGoodwill 214,523,000
2 PropertyPlantAndEquipmentNet 284,473,000
3 remainder_Assets 359,185,000
4 LiabilitiesCurrent 170,433,000
5 LiabilitiesNoncurrent 26,674,000
6 remainder_Liabilities 388,773,000
7 CostOfGoodsAndServicesSold 91,830,000
8 SellingGeneralAndAdministrativeExpense 198,173,000
9 ResearchAndDevelopmentExpense 302,218,000
10 remainder_Expenses 22,425,000
11 remainder_Revenues 500,723,000
12 remainder_NetIncome -424,000
13 remainder_ComprehensiveNetIncome -5,089,000
  yvar yval
0 Assets 1,601,643,000
1 Liabilities 585,880,000
2 Expenses 614,646,000
3 Revenues 500,723,000
4 StockholdersEquity 1,015,763,000
5 NetIncome -114,347,000
6 ComprehensiveNetIncome -116,891,500
7 BaseVar 1,654,202,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.92
9 EconomicCapitalRatio 2.97

Edgar->Model Mapping

Feature Distribution

Change over Time